Brivaracetam and Dyspnea exacerbated - a phase IV clinical study of FDA data

Summary:

Dyspnea exacerbated is reported as a side effect among people who take Brivaracetam (brivaracetam), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Lantus, and have Epilepsy.

The phase IV clinical study analyzes which people have Dyspnea exacerbated when taking Brivaracetam. It is created by eHealthMe based on reports of 3,318 people who have side effects when taking Brivaracetam from the FDA, and is updated regularly.

What is Brivaracetam?

Brivaracetam has active ingredients of brivaracetam. eHealthMe is studying from 3,319 Brivaracetam users. Check the latest studies of Brivaracetam.

What is Dyspnea exacerbated?

Dyspnea exacerbated is found to be associated with 3,270 drugs and 1,653 conditions by eHealthMe. Check the latest studies of Dyspnea exacerbated.

On Jul, 06, 2026

3,318 people reported to have side effects when taking Brivaracetam.
Among them, 32 people (0.96%) have Dyspnea exacerbated.

Could Brivaracetam cause Dyspnea exacerbated?

Among these 32 people:

How long have people been on Brivaracetam when they have Dyspnea exacerbated? *

What is the gender of people who have Dyspnea exacerbated when taking Brivaracetam? *

female: 28.57 %
male: 71.43 %

What is the age of people who have Dyspnea exacerbated when taking Brivaracetam? *

What are other drugs people take besides Brivaracetam? *

What are other side effects people have besides Dyspnea exacerbated? *

Fatigue (feeling of tiredness): 13 people, 40.62%
Weight Increased: 9 people, 28.12%
Ankle Fracture: 9 people, 28.12%
Blood Pressure Systolic Increased: 9 people, 28.12%
Blood Pressure Diastolic Decreased: 9 people, 28.12%
Sleep Disorder: 9 people, 28.12%
Feeling Abnormal: 9 people, 28.12%
Dyspnea At Rest: 9 people, 28.12%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 9 people, 28.12%
Intervertebral Disc Protrusion (spinal disc protrusion): 9 people, 28.12%

What are the existing conditions these people have? *

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 11 people, 34.38%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 18.75%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 6.25%
Muscle Spasms (muscle contraction): 2 people, 6.25%
Migraine (headache): 2 people, 6.25%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 3.12%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 3.12%
Athlete's Foot (a fungal infection affecting the skin between the toes): 1 person, 3.12%
Birth Control: 1 person, 3.12%
Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 1 person, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Brivaracetam and have Dyspnea exacerbated?

- Check whether Dyspnea exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Brivaracetam:

Brivaracetam (3,319 reports)

Browse all side effects of Brivaracetam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (3,270 drugs)

Browse all the conditions that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (1,653 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on brivaracetam (the active ingredients of Brivaracetam) and Brivaracetam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.